Valeant
-
Valeant offers discounts for two drugsValeant Pharmaceuticals says it is offering rebates on the price of two heart drugs that have come under scrutiny by the U.S. Congress.MoneyMay 16, 2016
-
Quebec drugmaker Valeant doubled price of drug used for assisted deathA Quebec drug company is facing criticism for doubling the price of a drug used in doctor-assisted death in the United States.HealthMar 25, 2016
-
Valeant Pharmaceuticals CEO J. Michael Pearson to step downThe chief executive of embattled Valeant Pharmaceuticals is leaving.CanadaMar 21, 2016
![]()
-
Tough year for business gave rise to bewildering corporate speakFrom disruptive synergies to opening the kimono, corporate speak can range from the mildly irritating to the entirely bewildering. Here's some classics from the past 12 months.CanadaDec 30, 2015
![]()
-
Head of Canadian drugmaker Valeant says he will ‘listen’ to criticsCEO says he wants input from patients and critics as the company tries to withstand intense political scrutiny over allegations of price gouging.CanadaNov 10, 2015
![]()
-
Company behind 5,000% drug price hike being investigated by US SenatePublic anxiety over rising drug prices has prompted a U.S. Senate committee to launch an investigation into Turing Pharmaceuticals, Canada's Valeant Pharmaceuticals, and two other drugmakers.HealthNov 4, 2015
![]()
-
U.S. Senate officially launches probe into Canadian drug firm ValeantThe political scrutiny of Valeant Pharmaceuticals is heating up as the U.S. Senate formally launched a probe Wednesday into skyrocketing prices for three of the company's prescription drugs.CanadaNov 4, 2015
![]()
-
Valeant to cut all ties with PhilidorValeant Pharmaceuticals says it's cutting all ties with Philidor Rx Services, a partner company at the centre of a controversy about how Canada's largest publicly traded drug company conducts its business.MoneyOct 30, 2015
![]()
-
Drug maker Valeant sees stock plunge 30%, trading haltedTrading in Valeant Pharmaceutical shares was briefly halted today on the Toronto Stock Exchange as its stock fell 30 per cent in morning trading.CanadaOct 21, 2015
![]()
-
Drug maker Valeant expects higher profits despite U.S. pricing probeQuebec-based pharmaceutical giant says 2015 is shaping up to be more profitable than it thought, even as it undergoes scrutiny for dramatic price hikes.ConsumerOct 19, 2015
![]()
